Tuesday, October 27, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

NCT07782359 · PHASE1 · RECRUITING · Sponsor: University of Chicago · Conditions: Lung

PR
By Priya Raman · Science Reporter
Oct 27 08:00 ETSource: ClinicalTrials.gov

From the source

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

NCT07782359 · PHASE1 · RECRUITING · Sponsor: University of Chicago · Conditions: Lung Cancer.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →